Aquestive Therapeutics AQST 深 滬
等待開盤 09-20 09:30:00 美东时间
5.20
+0.250
+5.05%
華盛通- 最 高5.20
- 今 開5.14
- 成交量 116.47万股
- 最 低 4.954
- 昨 收 4.95
- 總市值 3.81亿
- 52周最高 6.23
- 市盈率 靜 --
- 換手率 1.59%
- 52周最低 1.2514
- 委 比 -61.34%
- 總股本 7330.12万
- 歷史最高 20.696
- 量 比 1.00
- 振 幅 4.97%
- 歷史最低 0.618
- 每 手 1
- 風險率 1.08%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Small-cap stocks have climbed recently. Here are the ones most poised for further upside
Small cap stocks (NYSEARCA:IWM) are up almost 2% from a month ago. This comes as investors make bets ahead of an expected rate cut from the Federal Reserve. Investors are predicting an aggressive rate...
09-17 04:15
Aquestive Therapeutics Outlines Growth and Product Progress
An announcement from Aquestive Therapeutics ( ($AQST) ) is now available. Aques...
09-09 21:18
快讯 | Aquestive Therapeutics就最近FDA批准的非注射性肾上腺素过敏治疗产品发表评论，并重申对Anaphylm™ NDA申请的预期时间。
Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based E...
08-14 20:00
快讯 | aquestive therapeutics：重申预计在2025年Q1向FDA提交Anaphylm亚舌下膜片的新药申请。
Aquestive Therapeutics : Reiterates Expected Timing for Filing Nda for Anaphylm...
08-14 20:00
Raymond James ups ARS to strong buy, cites FDA neffy approval
Raymond James has raised ARS Pharmaceuticals (NASDAQ:SPRY) to strong buy, citing the recent approval of its epinephrine nasal spray, neffy. Noting that FDA approval for the product came earlier than e...
08-14 00:26
Aquestive Therapeutics Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-12 21:58
Oppenheimer sees Aquestive benefitting from FDA okay of rival drug
Oppenheimer said the FDA’s approval of ARS Pharmaceuticals’ (SPRY) epinephrine nasal spray for severe allergic reactions de-risks the regulatory path for Aquestive Therapeutics (NASDAQ:AQST) oral form...
08-10 03:00
快讯 | Aquestive Therapeutics公司预计2024年的总收入将达到约5700万美元至6000万美元。
Aquestive Therapeutics Inc -Sees 2024 Total Revenues of About $57 Mln - $60 Mln
08-07 05:25
快讯 | Aquestive Therapeutics，Inc.第二季度营业收入为2009.9美元，相较于IBES估算的1240万美元有所增长。
Aquestive Therapeutics, Inc. Q2 Revenue USD 20.099 Million Vs. IBES Estimate US...
08-07 04:22
新浪财经ESG：Aquestive Therapeutics Inc. 路孚特（Refinitiv）ESG评级调降至D
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
07-30 07:03
